发明名称 |
Anvendelse av buprenorfin i fremstilling av et medikament |
摘要 |
A sustained release formulation of buprenorphine is new. The composition comprises a transdermal delivery device which provides a first order release of buprenorphine over a 3-day dosing interval so that a maximum plasma concentration of 20 10 1052 pg/ml is obtained. the device then provides zero order kinetics over at least 2 more days. |
申请公布号 |
NO20064395(A) |
申请公布日期 |
1999.10.22 |
申请号 |
NO20060004395 |
申请日期 |
2006.09.28 |
申请人 |
EURO-CELTIQUE SA |
发明人 |
KAIKO ROBERT FRANCIS;GOLDENHEIM PAUL;REDER ROBERT F |
分类号 |
A61K31/485;A61F13/00;A61K9/22;A61K9/70;A61K31/00;A61P25/00;A61P25/04;A61P29/00 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|